These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18853421)

  • 1. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
    Yau T; Yao TJ; Chan P; Ng K; Fan ST; Poon RT
    Cancer; 2008 Nov; 113(10):2742-51. PubMed ID: 18853421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators.
    Hepatology; 2000 Apr; 31(4):840-5. PubMed ID: 10733537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
    Kudo M; Chung H; Osaki Y
    J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
    Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
    Hepatology; 1998 Sep; 28(3):751-5. PubMed ID: 9731568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F; Rinaldi M; Gianni S; Naccarato R
    Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
    Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.
    Ueno S; Tanabe G; Sako K; Hiwaki T; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    Hepatology; 2001 Sep; 34(3):529-34. PubMed ID: 11526539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
    Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
    Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
    Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
    J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
    Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
    Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
    Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
    Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
    Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
    Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
    Tateishi R; Yoshida H; Shiina S; Imamura H; Hasegawa K; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Makuuchi M; Omata M
    Gut; 2005 Mar; 54(3):419-25. PubMed ID: 15710994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
    Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
    Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Huang YH; Lin HC; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Am J Gastroenterol; 2006 May; 101(5):975-82. PubMed ID: 16573785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.